No Data
Recce Reaches Key Dosing Milestone in Testing of Skin Infection Gel
Recce Pharmaceuticals Participants Meet Primary Endpoints as Phase 2 Trial of Topical Gel Nears End
Recce Pharmaceuticals' R327 Gel Shows Promising Trial Results
Recce Pharmaceuticals Unanimously Supported by Independent Safety Review to Forge Ahead With ABSSSI Clinical Trial | ASX:RCE, OTC:RECEF
Recce Pharmaceuticals Advances in Skin Infection Trial
Recce Pharmaceuticals Ltd: Annual Report to Shareholders
Press Release: Recce Pharmaceuticals Receives AUD $11.17 Million Research and Development (R&D) AdvanceNo Data
No Data
